-
Board Certification
American Board of Dermatology (Dermatology)American Board of Dermatology (Sub: Micrographic Dermatologic Surgery)Patient Rating
4.9 /5( out of 89 reviews )The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.
The scale on which responses are measured is 1 to 5 with 5 being the best score.
Patient Comments
Patient comments are gathered from our patient experience survey and displayed in their entirety.
Patients are de-identified for confidentiality and patient privacy.October 31, 2024HUNTSMAN CANCER CENTERDr. Tristani was amazing and made me feel comfortable and was very attentive to me. It was a very positive experience.
October 31, 2024UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTERShe is kind and thorough. Dr. Tristani made sure everything looked great and gave detailed aftercare which was appreciated.
October 30, 2024HUNTSMAN CANCER CENTER2nd Mohs treatment from her. Excellent results.
October 29, 2024HUNTSMAN CANCER CENTERExcellent surgeon. I have very little scarring after three Mohs surgery procedures .
October 18, 2024HUNTSMAN CANCER CENTERDr. is very professional and thorugh in her work.
October 17, 2024UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTERDr. Tristani-Firouzi is an excellent health care provider. Ογ½ΆΚΣΖ΅ of Utah Health is lucky to have her.
October 16, 2024FARMINGTON HEALTH CENTERExtremely knowledgeable and professional.
October 16, 2024FARMINGTON HEALTH CENTERVery talented and caring physician.
October 10, 2024HUNTSMAN CANCER CENTERDr. Tristani is a very skilled and knowledgeable doctor.
-
Board Certification and Academic Information
Academic Departments Dermatology -Primary Board Certification American Board of Dermatology (Dermatology)American Board of Dermatology (Sub: Micrographic Dermatologic Surgery)Education history
Fellowship Mohs Micrographic Surgery - Ογ½ΆΚΣΖ΅ of Utah School of Medicine Fellow Residency Dermatology - Ογ½ΆΚΣΖ΅ of Utah School of Medicine Resident Fellowship Dermatology - Ογ½ΆΚΣΖ΅ of Utah School of Medicine Fellow Internship Internal Medicine - Ογ½ΆΚΣΖ΅ of Utah School of Medicine Intern Professional Medical Medicine - Ογ½ΆΚΣΖ΅ of Minnesota M.D. Graduate Training Laboratory Medicine and Pathology - Ογ½ΆΚΣΖ΅ of Minnesota Master's Undergraduate Medical Technology - Ογ½ΆΚΣΖ΅ of Minnesota B.S. Selected Publications
Journal Article
- Donigan JM, Srivastava D, Maher I, Abdelmalek M, Bar AA, Blalock TW, Bordeaux JS, Brodland DG, Carroll BT, Council ML, Duffy K, Fathi R, Golda N, Johnson-Jahangir H, Konda S, Leitenberger JJ, Moye M, Nelson JL, Patel VA, Shaffer JJ, Soltani-Arabshahi R, Tristani-Firouzi P, Tschetter AJ, Nijhawan RI (2020). Opioid Prescribing Recommendations After Mohs Micrographic Surgery and Reconstruction: A Delphi Consensus. Dermatol Surg, 47(2), 167-169. ()
- Donigan JM, Franco AI, Stoddard GJ, Hedderman A, Tristani-Firouzi P, Bowen GM, Millican EA, Duffy KL (2018). Opioid Prescribing Patterns After Micrographic Surgery: A Follow-up Retrospective Chart Review. Dermatol Surg, 45(4), 508-513. ()
- Saluja SS, Walker ML, Summers EM, Tristani-Firouzi P, Smart DR (2017). Safety of non-ablative fractional laser for acne scars within 1 month after treatment with oral isotretinoin: A randomized split-face controlled trial. Lasers Surg Med, 49(10), 886-890. ()
- Hyde MA, Hadley ML, Tristani-Firouzi P, Goldgar D, Bowen GM (2012). A randomized trial of the off-label use of imiquimod, 5%, cream with vs without tazarotene, 0.1%, gel for the treatment of lentigo maligna, followed by conservative staged excisions. Arch Dermatol, 148(5), 592-6. ()
- Hadley J, Tristani-Firouzi P, Hull C, Florell S, Cotter M, Hadley M (2012). Results of an investigator-initiated single-blind split-face comparison of photodynamic therapy and 5% imiquimod cream for the treatment of actinic keratoses. Dermatol Surg, 38(5), 722-7. ()
- Bowen AR, Burt L, Boucher K, Tristani-Firouzi P, Florell SR (2012). Use of proliferation rate, p53 staining and perforating elastic fibers in distinguishing keratoacanthoma from hypertrophic lichen planus: a pilot study. J Cutan Pathol, 39(2), 243-50. ()
- Foo CW, Tristani-Firouzi P (2011). Topical modalities for treatment and prevention of postsurgical hypertrophic scars. Facial Plast Surg Clin North Am, 19(3), 551-7. ()
- Hadley JC, Tristani-Firouzi P, Florell SF, Bowen GM, Hadley ML (2009). Case series of multiple recurrent reactive keratoacanthomas developing at surgical margins. Dermatol Surg, 35(12), 2019-24. ()
- Duffy KL, Bowen AR, Tristani-Firouzi P, Florell SR, Hadley ML (2009). Eccrine syringofibroadenoma-like change adjacent to a squamous cell carcinoma: potential histologic pitfall in Mohs micrographic surgery. Dermatol Surg, 35(3), 519-22. ()
- Duffy KL, Florell SR, Tristani-Firouzi P, Bowen AR, Hadley ML (2009). Syringocystadenomatous-like change adjacent to a squamous cell carcinoma: Potential Mohs Micrographic Surgery pitfall. Dermatol Surg, 35(3), 519-22.
- Duffy KL, McKenna JK, Hadley ML, Tristani-Firouzi P (2009). Nonmelanoma skin cancers of the ear: correlation between subanatomic location and post-Mohs micrographic surgery defect size. Dermatol Surg, 35(1), 30-3. ()
- Hadley JC, Tristani-Firouzi P, Florell SF, Bowen GM, Hadley ML (2009). Case Series of Multiply Recurrent Reactive Keratoacanthoma Developing at Surgical Margins. Dermatol Surg, 35(12), 2019-24.
-
News & Podcasts
Podcasts
( out of 89 reviews )